etuvetidigene autotemcel (waskyra)
etuvetidigene autotemcel is an FDA-licensed reference biologic from Fondazione Telethon Ets. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2025
Reference approved
Reference product
waskyra etuvetidigene autotemcel
Fondazione Telethon Ets
- Approved
- Dec 09, 2025
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for etuvetidigene autotemcel, in chronological order.
Reference approval
Approval date of the reference etuvetidigene autotemcel product.
6 mo ago
Frequently asked questions
Are there biosimilars approved for etuvetidigene autotemcel (waskyra)?
No 351(k) biosimilars or interchangeable biosimilars referencing etuvetidigene autotemcel are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.